IN BRIEF: Diaceutics teams with diagnostic test manufacturer SeraCare
IN BRIEF: Diaceutics teams with diagnostic test manufacturer SeraCare
Read moreThu, 21st Mar 2019 09:55
IN BRIEF: Diaceutics teams with diagnostic test manufacturer SeraCare
Read moreDIRECTOR DEALINGS: Filta Non-Exec Sayers sells GBP1.7 million worth
Read moreEXECUTIVE CHANGES: Eland Oil founder now Vaalco CEO; Dialight CFO out
Read moreIN BRIEF: Diaceutics wins deal to provide Covid testing analysis in US
Read more(Sharecast News) - Diaceutics has secured a data licensing agreement with an unnamed global pharmaceutical company to provide Covid-19 testing data insights in the US, it announced on Thursday, enabled by its proprietary diagnostic network 'DXRX'.
Read moreIN BRIEF: Diaceutics inks deal to move to new head office
Read moreTRADING UPDATES: Ocean Wilsons annual profit slips; dividend unchanged
Read more(Sharecast News) - Diaceutics updated the market on its trading in 2020 on Monday, reporting that its revenue and adjusted EBITDA for the year ended 31 December were expected to be around £12.6m, down from £13.4m, and £0.5m, down from £2.2m respectively, with EBITDA breakeven.
Read moreIN BRIEF: Diaceutics Says 2020 Earnings To Beat Market Forecasts
Read moreIN BRIEF: Diaceutics Taps Former PayPal And eBay Exec As New Chair
Read moreUK TRADING UPDATE SUMMARY: Shoe Zone Ends Financial Year On Back Foot
Read more(Sharecast News) - Diaceutics announced the launch of its 'DXRX - The Diagnostic Network digital platform on Wednesday, which it said was designed to accelerate the development and commercialisation of precision medicine diagnostics using a new operating model.
Read moreDiaceutics Shakes Off Virus In First Half But Cautions On Full-Year
Read moreIN BRIEF: Diaceutics Wins Big Contract For US With Pharmaceutical Firm
Read more(Sharecast News) - Diagnostic commercialisation company Diaceutics announced a new, "significant" client contract win with an unnamed pharmaceutical company on Wednesday.
Read more